Harish Ramanathan is an Associate Principal Scientist at Merck & Co., bringing over 18 years of expertise in biomedical research encompassing rare genetic diseases, molecular virology, innate immunity, and cancer biology. Previously, Harish contributed to the development of medications for anemia at Acceleron Pharma and conducted significant research at Yale University School of Medicine in antiviral discovery. Harish has published numerous articles in respected scientific journals and possesses extensive experience in assay development and mechanism of action studies. With a strong focus on translational research, Harish aims to advance targeted therapeutics from bench to bedside.
This person is not in the org chart
This person is not in any teams
This person is not in any offices